$RENX Income Statement | Understand Stock

$RENX

$1.03 -$0.19 (15.57%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023
Revenue
Sales
Total revenue
Cost of revenue
Commissions
Costs of revenue
Total cost of revenue
Gross profit
Operating expenses:
Payroll and related expenses
General and administrative expenses
Professional and consulting fees
Marketing and business development expense
Impairment loss
Bad debt expense
Total
Operating loss
Interest expense
Other income (expense):
Interest expense
Change in fair value of derivative liability
Impairment of notes receivable
Gain on sale of land
Interest income
Other income
Total
Net loss
Deemed dividends related to preferred stock B derivative value
Net loss allocable to common shareholders
Net loss per share
Basic (in Dollars per share)
Diluted (in Dollars per share)
Weighted average shares outstanding:
Basic (in Shares)
Diluted (in Shares)

Comments